BUENOS AIRES, Argentina – Plantpraxis – a melding of Axis Biotech Brasil, of Rio de Janeiro, and Canadian biotech Plantform Corp. – is on track to dent the costs of expensive biologic treatments in developing countries, according to Axis CEO Eduardo Cruz.

BUENOS AIRES, Argentina – Andes Biotechnologies SA, a cancer drug company from Santiago, Chile, is planning to cement its presence in the U.S. as it begins to emerge from stealth mode.

BUENOS AIRES, Argentina – In Colombia, guidelines for biosimilar regulation share a certain similarity with buses: wait for ages, then two come along at once. In August, three years after the Colombian government issued a decree mandating the ministry of health to establish regulations for biosimilars, two new guidelines – focusing on stability and immunogenicity – will be implemented.